Experience of Newly Diagnosed Patients With Sarcoma Receiving Chemotherapy

Clara Granda-Cameron

Alexandra Hanlon

Mary Pat Lynch

Arlene D. Houldin

patient fears, chemotherapy, diagnosis
ONF 2011, 38(2), 160-169. DOI: 10.1188/11.ONF.160-169

Purpose/Objectives: To examine symptom distress and quality of life (QOL) in newly diagnosed patients with sarcoma receiving chemotherapy.

Design: Pilot study; descriptive, quantitative.

Setting: Urban community cancer center in the northeastern United States.

Sample: 11 newly diagnosed patients with sarcoma.

Methods: Participants completed the Edmonton Symptom Assessment Scale and the Functional Assessment of Cancer Therapy-General at baseline and on days 1, 15, and 21 of their chemotherapy treatment.

Main Research Variables: Symptom distress and QOL.

Findings: Fatigue was the most prevalent and pervasive symptom. Anxiety, well-being, lack of appetite, drowsiness, and depression were the most commonly reported symptoms during chemotherapy. QOL was negatively affected. The lowest mean score reported was for functional well-being. Outcome profiles for symptom distress increased over time, whereas QOL profiles decreased over time. Exploratory analyses of age, race, sex, and diagnosis group suggested differences that warrant further study.

Conclusions: Overall, increasing symptom distress and reduced QOL over time were reported by patients with sarcoma during chemotherapy. Exploratory analysis by demographic variables and treatment group suggested the need for further research of predictors for symptom distress and QOL.

Implications for Nursing: Clinical and research implications included the need for better understanding about symptom distress and QOL predictors in patients with sarcoma, as well as the evaluation of interventions directed to address this population's specific needs.

Jump to a section


    Asknes, L. H., Bauer, H. C., Dahl, A. A., Fossa, S. D., Hjorth, L., Jebsen, N., … Hall, S. (2009). Health status at long-term follow-up in patients treated for extremity localized Ewing sarcoma or osteosarcoma: A Scandinavian sarcoma group study. Pediatric Blood Cancer, 53, 84-89. doi: 10.1002/pbc.22027
    Aksnes, L. H., Bauer, H. C., Jebsen, N. L., Folleras, G., Allert, C., Haugen, G. S., & Hall, K. S. (2008). Limb-sparing surgery preserves more function than amputation: A Scandinavian sarcoma group study of 118 patients. Journal of Bone and Joint Surgery, 90, 786-794.
    Aksnes, L. H., Hall, K. S., Jebsen, N., Fossa, S. D. & Dahl, A. A. (2007). Young survivors of malignant bone tumors in the extremities: A comparative study of quality of life, fatigue and mental distress. Supportive Care in Cancer, 15, 1087-1096.
    Anderson, K. O., Giralt, S. A., Mendoza, T. R., Brown, J. O., Neumann, J. L., Mobley, G. M., … Cleeland, C. S. (2007). Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplantation, 39, 759-766. doi: 10.1038/sj.bmt.1705664
    Beck, L. A., Einertson, M. J., Winemiller, M. H., DePompolo, R. W., Hoppe, K. M., & Sim, F. F. (2008). Functional outcomes and quality of life after tumor-related hemipelvectomy. Physical Therapy, 88, 916-927.
    Bleyer, A., Montello, M., Budd, T. & Saxman, S. (2005). National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation. Cancer, 103, 1891-1897.
    Bleyer, A., O'Leary, M., Barr, R., & Ries, L. A. G. (Eds.). (2006). Cancer epidemiology in older adolescents and young adults 15-29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, MD: National Cancer Institute.
    Bruley, D. K. (1999). Beyond reliability and validity: Analysis of selected quality of life instruments for use in palliative care. Journal of Palliative Medicine, 2, 299-309. doi: 10.1089/jpm.1999.2.299
    Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., … Brannon, J. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570-579.
    Chang, V. T., Hwang, S. S., & Feuerman, M. (2000). Validation of the Edmonton Symptom Assessment Scale. Cancer, 88, 2164-2171.
    Chang, V. T., Steinberg, S. M., Culnane, M., Lampert, M. H., Reggia, A. J., Simpson, C. G., … Glatstein, E. (1989). Functional and psychosocial effects of multimodality limb-sparing therapy in patients with soft tissue sarcomas. Journal of Clinical Oncology, 7, 1217-1228.
    Cheung, Y. B., Goh, C., Thumboo, J., Khoo, K. S., & Wee, J. (2005). Variability and sample size requirements of quality-of-life measures: A randomized study of three major questionnaires. Journal of Clinical Oncology, 23, 4936-4944. doi: 10.1200/JCO.2005.07.141
    Cormier, J. N., & Pollock, R. E. (2004). Soft tissue sarcomas. CA: A Cancer Journal for Clinicians, 54, 94-109. Retrieved from
    Daigeler, A., Lehnhardt, M., Khadra, A., Hauser, J., Steinstraesser, L., Langer, S., … Steinau, H. U. (2009). Proximal major limb amputations—A retrospective analysis of 45 oncological cases. World Journal of Surgical Oncology, 7, 15-24. doi: 10.1186/1477-7819-7-15
    Dodd, M. J., Miaskowski, C., & Paul, S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28, 465-470.
    Dorfman, H. D., & Czerniak, B. (1995). Bone cancers. Cancer, 75(1, Suppl.), 203-210.
    Eiser, C., Darlington, A. S., Stride, C. B., & Grimer, R. (2001). Quality of life implications as a consequence of surgery: Limb salvage, primary and secondary amputation. Sarcoma, 5, 189-195.
    Epstein, J. B., Phillips, N., Parry, J., Epstein, M. S., Nevill, T., & Stevenson-Moore, P. (2002). Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 30, 785-792. doi: 10.1038/sj.bmt.1703716
    Frances, J. M., Morris, C. D., Arkader, A., Nikolic, Z. G., & Healey, J. H. (2007). What is quality of life in children with bone sarcoma? Clinical Orthopaedics and Related Research, 459, 34-39. doi: 10.1097/BLO.0b013e31804f545d
    Gielissen, M. F., Schattenberg, A. V., Verhagen, C. A., Rinkes, M. J., Bremmers, M. E., & Bleijenberg, G. (2007). Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplantation, 39, 595-603. doi: 10.1038/sj.bmt.1705624
    Gurney, J. G., Severson, R. K., Davis, S., & Robison, L. L. (1995). Incidence of cancer in children in the United States. Sex-, race-, and 1-year-age-specific rates by histologic type. Cancer, 75, 2186-2195.
    Hann, D. M., Jacobsen, P. B., Martin, S. C., Kronish, L. E., Azzarello, L. M., & Fields, K. K. (1997). Quality of life following bone marrow transplantation for breast cancer: A comparative study. Bone Marrow Transplantation, 19, 257-264. doi: 10.1038/sj.bmt.1700651
    Hartmann, J. T., & Patel, S. (2005). Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma. Drugs, 65, 167-178.
    Hassan, I., Cima, R. C., & Sloan, J. A. (2006). Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies. Gastroenterology Clinics of North America, 35, 53-64.
    Heinonen, H., Volin, L., Uutela, A., Zevon, M., Barrick, C., & Ruutu, T. (2001). Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplantation, 28, 503-509.
    Hjermstad, M. J., Knobel, H., Brinch, L., Fayers, P. M., Loge, J. H., Holte, H., & Kaasa, S. (2004). A prospective study of health-related quality of life, fatigue, anxiety, and depression 3-5 years after stem cell transplantation. Bone Marrow Transplantation, 34, 257-266. doi: 10.1038/sj.bmt.1704561
    Jebsen, N. L., Bruland, O. S., Eriksson, M., Engellau, J., Turesson, I., Folin, A., … Hall, K. S. (2010). Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. International Journal of Radiation Oncology Biology Physics. Advance online publication. doi: 10.1016/j.ijrobp.2010.07.037
    Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer statistics, 2010. CA: A Cancer Journal for Clinicians, 60, 277-300. doi: 10.3322/caac.20073
    Maunsell, E., Pogany, L., Barrera, M., Shaw, A. K., & Speechley, K. N. (2006). Quality of life among long-term adolescent and adult survivors of childhood cancer. Journal of Clinical Oncology, 24, 2527-2535.
    McQuellon, R. P., Russell, G. B., Rambo, T. D., Craven, B. L., Radford, J., Perry, J. J., … Hurd, D. D. (1998). Quality of life and psychological distress of bone marrow transplant recipients: The "time trajectory" to recovery over the first year. Bone Marrow Transplantation, 21, 477-486. doi: 10.1038/sj.bmt.1701115
    Mor, V., Allen, S., & Malin, M. (1994). The psychosocial impact of cancer on older versus younger patients and their families. Cancer, 74(7, Suppl.), 2118-2127.
    National Comprehensive Cancer Network. (2011a). NCCN Clinical Practice Guidelines in Oncology™: Bone cancer [v.2.2011]. Retrieved from
    National Comprehensive Cancer Network. (2011b). NCCN Clinical Practice Guidelines in Oncology™: Bone cancer [v.2.2011]. Retrieved from
    Nielsen, O. S., Blay, J., Judson, I.R, van Glabbeke, M., Verweij, J., & van Oosterom, A. T. (2003). Metastatic soft tissue sarcoma in adults: Prognosis and treatment options. American Journal of Cancer, 2, 211-221.
    Parsons, J. A., & Davis, A. M. (2004). Rehabilitation and quality-of-life issues in patients with extremity soft tissue sarcoma. Current Treatment Options in Oncology, 5, 477-488.
    Payne, D. K., Lundberg, J. C., Brennan, M. F., & Holland, J. C. (1997). A psychosocial intervention for patients with soft tissue sarcoma. Psycho-Oncology, 6, 65-71.
    Pisters, P. (2002). Staging and prognosis. In R. E. Pollock (Ed.), American Cancer Society atlas of clinical oncology: Soft tissue sarcomas (pp. 80-88). Hamilton, Ontario, Canada: BC Decker.
    Refaat, Y., Gunnoe, J., Hornicek, F. J., & Mankin, H. J. (2002). Comparison of quality of life after amputation or limb salvage. Clinical Orthopaedics and Related Research, 397, 298-305.
    Ripamonti, C., & Dickerson, E. D. (2001). Strategies for the treatment of cancer pain in the new millennium. Drugs, 61, 955-977.
    Schreiber, D., Bell, R. S., Wunder, J. S., O'Sullivan, B., Turcotte, R., Masri, B. A., & Davis, A. M. (2006). Evaluating function and health related quality of life in patients treated for extremity soft tissue sarcoma. Quality of Life Research, 15, 1439-1446.
    Schultz-Kindermann, F., Hennings, U., Ramm, G., Zander, A. R., & Hasenbring, M. (2002). The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marrow Transplantation, 29, 341-351. doi: 10.1038/sj.bmt.1703385
    Servaes, P., Verhagen, S., Schreuder, H. W., Veth, R. P., & Bleijenberg, G. (2003). Fatigue after treatment for malignant and benign bone and soft tissue tumors. Journal of Pain and Symptom Management, 26, 1113-1122.
    Sherman, A. C., Simonton, S., Latif, U., Spohn, R., & Tricot, G. (2004). Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplantation, 33, 955-962. doi: 10.1038/sj.bmt.1704465
    Smith, M. Y., Redd, W. H., Peyser, C., & Vogl, D. (1999). Post-traumatic stress disorder in cancer: A review. Psycho-Oncology, 8, 521-537.
    Spears, J. (2008). Emotional support given by ward-based nurses to sarcoma patients. European Journal of Oncology Nursing, 12, 334-341. doi: 10.1016/j.ejon.2008.03.001
    Sugarbaker, P. H., Barofsky, I., Rosenberg, S. A., & Gianola, F. J., (1982). Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery, 91, 17-23.
    Thijssens, K., Hoekstra-Weebers, J., Ginkel, R., & Hoekstra, H. (2006). Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma. Annals of Surgical Oncology, 13, 864-871. doi: 10.1245/ASO.2006.05.023
    Unni, K. K. (1996). Dahlin's bone tumors: General aspects and data on 11,087 cases (5th ed.). Philadelphia, PA: Lippincott-Raven.
    Weddington, W. W., Jr., Segraves, K. B., & Simon, M. A. (1985). Psychological outcome of extremity sarcoma survivors undergoing amputation or limb salvage. Journal of Clinical Oncology, 3, 1393-1399.
    Wettergren, L., Langius, A., Bjorkholm, M., & Bjorvell, H. (1997). Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation—A prospective study. Bone Marrow Transplantation, 20, 497-502.
    Womer, R. B. (1996). Problems and controversies in the management of childhood sarcomas. British Medical Bulletin, 52, 826-843.
    Zahm, S. H., & Fraumeni, J. F., Jr. (1997). The epidemiology of soft tissue sarcoma. Seminars in Oncology, 24, 504-514.
    Zimmerman, L., Story, K. T., Gaston-Johansson, F., & Rowles, J. R. (1996). Psychological variables and cancer pain. Cancer Nursing, 19, 44-53.